Copy to clipboard 
Umbra Companies (UCI) initiated the acquisition of Ossifix Orthopedics.
Ossifix products, like the Infinity NPCP® Integrating Plate System shown above, are made from high-density allograft cortical bone that supports secure fixation and eliminates allergic or autoimmune reactions associated with metal or plastic/polymer implants.
Other Ossifix products include the Torus® ACL Interference Screw, Janus® Integrating Bioabsorbable Pin for fractures, fusions, and osteotomies and the Quantum® Recon Screw for the repair of metacarpal and phalangeal fusion and fractures.
All Ossifix Orthopedics Pin, Screw and Plate systems are single-use surgical kits including all necessary instruments, and are based on decades of clinical experience and use in the operating room. Instrumentation is constructed of an eco-friendly, bio-degradable polymer.
Ossifix currently works with Umbra Applied Technologies (UAT) to develop biodegradable polymer-based surgical instrumentation engineered with their antimicrobial technology brand, Hygieia.
Ossifix CEO Mark Estrada said, “I have a longstanding relationship with all the folks over at UAT and UCI, which made it a no brainer to join forces. My team and I are very excited about this move and we are eager to show everyone what the future holds.”
Umbra CEO Alex Umbra said, “We are pleased to integrate Ossifix into our growing suite of companies. I, as well as the rest of the team, look forward to building the synergy across all of our subsidiary companies by combining the resources and market footprints of all our companies. We believe that this ‘growth through acquisition approach’ will serve to exponentially expand our capabilities so that we can gain a competitive edge in relevant market spaces. I have no doubt that the addition of Ossifix to the Umbra family will be a significant contributor to our collective success.”
UCI is an investment holdings firm that deploys capital and resources. UCI invests in public and private companies during early stages of development, as well as growth stages of companies.
Umbra Companies (UCI) initiated the acquisition of Ossifix Orthopedics.
Ossifix products, like the Infinity NPCP® Integrating Plate System shown above, are made from high-density allograft cortical bone that supports secure fixation and eliminates allergic or autoimmune reactions associated with metal or plastic/polymer implants.
Other...
Umbra Companies (UCI) initiated the acquisition of Ossifix Orthopedics.
Ossifix products, like the Infinity NPCP® Integrating Plate System shown above, are made from high-density allograft cortical bone that supports secure fixation and eliminates allergic or autoimmune reactions associated with metal or plastic/polymer implants.
Other Ossifix products include the Torus® ACL Interference Screw, Janus® Integrating Bioabsorbable Pin for fractures, fusions, and osteotomies and the Quantum® Recon Screw for the repair of metacarpal and phalangeal fusion and fractures.
All Ossifix Orthopedics Pin, Screw and Plate systems are single-use surgical kits including all necessary instruments, and are based on decades of clinical experience and use in the operating room. Instrumentation is constructed of an eco-friendly, bio-degradable polymer.
Ossifix currently works with Umbra Applied Technologies (UAT) to develop biodegradable polymer-based surgical instrumentation engineered with their antimicrobial technology brand, Hygieia.
Ossifix CEO Mark Estrada said, “I have a longstanding relationship with all the folks over at UAT and UCI, which made it a no brainer to join forces. My team and I are very excited about this move and we are eager to show everyone what the future holds.”
Umbra CEO Alex Umbra said, “We are pleased to integrate Ossifix into our growing suite of companies. I, as well as the rest of the team, look forward to building the synergy across all of our subsidiary companies by combining the resources and market footprints of all our companies. We believe that this ‘growth through acquisition approach’ will serve to exponentially expand our capabilities so that we can gain a competitive edge in relevant market spaces. I have no doubt that the addition of Ossifix to the Umbra family will be a significant contributor to our collective success.”
UCI is an investment holdings firm that deploys capital and resources. UCI invests in public and private companies during early stages of development, as well as growth stages of companies.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
